RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.

Related Reports

Market Research Reports provided by reports.iptechex.com
Malignant Mesothelioma - Pipeline Review, Q3 2011
Jul 2011 - 220 pages - $500
Malignant Mesothelioma - Pipeline Review, Q1 2011
Jan 2011 - 50 pages - $500
Malignant Mesothelioma Global Clinical Trials Review, Q4, 2010
Dec 2010 - 62 pages - $1,000
Malignant Mesothelioma Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Jul 2011 - 74 pages - $2,000
Lung Cancer - Pipeline Review, Q3 2011
Jul 2011 - 837 pages - $500
Non-Small Cell Lung Cancer - Pipeline Review, Q1 2011
Feb 2011 - 538 pages - $500
Advancing Molecular Diagnostics to Personalize Cancer Therapy
Jun 2011 - 187 pages - $3,835
Lung Cancer and Non-Small Cell Lung Cancer Therapy Area Pipeline Report
Nov 2010 - 1535 pages - $1,495
MolMed S.p.A. – Product Pipeline Review – H2 2011
Oct 2011 - 63 pages - $500
Metastatic Lung Cancer - Pipeline Review, Q4 2010
Dec 2010 - 29 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Drug discovery del
Therapeutic target
Oncology del
Lung cancer del
Malignant mesothelioma del

Browse By

Industry sector
Bioinformatics
Combinatorial biology
Combinatorial chemistry
Drug research platforms
Genomics
High throughput screening
Proteomics
Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us